請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/16884
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 劉振軒 | |
dc.contributor.author | Chung-Chun Sha | en |
dc.contributor.author | 沙中群 | zh_TW |
dc.date.accessioned | 2021-06-07T23:48:51Z | - |
dc.date.copyright | 2014-03-09 | |
dc.date.issued | 2014 | |
dc.date.submitted | 2014-02-14 | |
dc.identifier.citation | 劉振軒. 臺灣北部地區犬貓死亡原因調查. 行政院農業委員會動植物防疫檢疫局主管科技計畫, 2012.
Affolter VK, and Moore PF. Localized and disseminated histiocytic sarcoma of dendritic cell origin in dogs. Vet Pathol 39: 74-83, 2002. Albers TM, Alroy J, Garrod LA, Brown D, and Penninck D. Histochemical and ultrastructural characterization of primary cardiac chondrosarcoma. Vet Pathol 34: 150-151, 1997. Andreasen CB, and Mahaffey EA. Immunohistochemical demonstration of desmin in canine smooth muscle tumors. Vet Pathol 24: 211-215, 1987. Aronsohn MG, Dubiel B, Roberts B, and Powers BE. Prognosis for Acute Nontraumatic Hemoperitoneum in the Dog: A Retrospective Analysis of 60 Cases (2003–2006). J Am Anim Hosp Assoc 45: 72-77, 2009. Baldo CF, Garcia-Pereira FL, Nelson NC, Hauptman JG, and Shih AC. Effects of anesthetic drugs on canine splenic volume determined via computed tomography. Am J Vet Res 73: 1715-1719, 2012. Balogh P, Horvath G, and Szakal AK. Immunoarchitecture of distinct reticular fibroblastic domains in the white pulp of mouse spleen. J Histochem Cytochem 52: 1287-1298, 2004. Banchereau J, and Palucka AK. Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol 5: 296-306, 2005. Banks PM, Chan J, Cleary ML, Delsol G, De Wolf-Peeters C, Gatter K, Grogan TM, Harris NL, Isaacson PG, Jaffe ES, and et al. Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data. Am J Surg Pathol 16: 637-640, 1992. Baskin CR, Couto CG, and Wittum TE. Factors influencing first remission and survival in 145 dogs with lymphoma: a retrospective study. J Am Anim Hosp Assoc 36: 404-409, 2000. Benjamin SA, Hahn FF, Chieffelle TL, Boecker BB, and Hobbs CH. Occurrence of hemangiosarcomas in beagles with internally deposited radionuclides. Cancer Res 35: 1745-1755, 1975. Bertazzolo W, Dell'Orco M, Bonfanti U, Ghisleni G, Caniatti M, Masserdotti C, Antoniazzi E, Crippa L, and Roccabianca P. Canine angiosarcoma: cytologic, histologic, and immunohistochemical correlations. Vet Clin Pathol 34: 28-34, 2005. Bettini G, Mandrioli L, Brunetti B, and Marcato P. Canine splenic pathology: a retrospective study of 109 surgical samples, with special emphasis on fibrohistiocytic nodules. Eur J Vet Pathol 7: 101-110, 2001. Block JB. Vinyl chloride and angiosarcoma. J Ky Med Assoc 72: 483-485, 1974. Boyce KL, and Kitchell BE. Treatment of canine lymphoma with COPLA/LVP. J Am Anim Hosp Assoc 36: 395-403, 2000. Boysen SR, Rozanski EA, Tidwell AS, Holm JL, Shaw SP, and Rush JE. Evaluation of a focused assessment with sonography for trauma protocol to detect free abdominal fluid in dogs involved in motor vehicle accidents. J Am Vet Med Assoc 225: 1198-1204, 2004. Brown NO, Patnaik AK, and MacEwen EG. Canine hemangiosarcoma: retrospective analysis of 104 cases. J Am Vet Med Assoc 186: 56-58, 1985. Buntain WL, and Lynn HB. Splenorrhaphy: changing concepts for the traumatized spleen. Surgery 86: 748-760, 1979. Cardy RH, and Bostrom RE. Multiple splenic myelolipomas in a cheetah (Acinonyx jubatus). Vet Pathol 15: 556-558, 1978. Casadei R, Ricci M, Ruggieri P, Biagini R, Benassi S, Picci P, and Campanacci M. Chondrosarcoma of the soft tissues. Two different sub-groups. J Bone Joint Surg Br 73: 162-168, 1991. Chang KL, Arber DA, Shibata D, Rappaport H, and Weiss LM. Follicular small lymphocytic lymphoma. Am J Surg Pathol 18: 999-1009, 1994. Chikata S, Nakamura S, Katayama R, Yanagisawa S, Matsuo Y, Yamane I, and Takahashi K. Primary chondrosarcoma in the liver of a dog. Vet Pathol 43: 1033-1036, 2006. Christensen N, Canfield P, Martin P, Krockenberger M, Spielman D, and Bosward K. Cytopathological and histopathological diagnosis of canine splenic disorders. Aust Vet J 87: 175-181, 2009. Clifford CA, Mackin AJ, and Henry CJ. Treatment of canine hemangiosarcoma: 2000 and beyond. J Vet Intern Med 14: 479-485, 2000. Cole PA. Association of canine splenic hemangiosarcomas and hematomas with nodular lymphoid hyperplasia or siderotic nodules. J Vet Diagn Invest 24: 759-762, 2012. Dahl K, Gamlem H, Tverdal A, Glattre E, and Moe L. Canine vascular neoplasia--a population-based study of prognosis. APMIS Suppl 55-62, 2008. Davis GJ, and Holt D. Two chondrosarcomas in the urethra of a German shepherd dog. J Small Anim Pract 44: 169-171, 2003. Day MJ, Lucke VM, and Pearson H. A review of pathological diagnoses made from 87 canine splenic biopsies. J Small Anim Pract 36: 426-433, 1995. De Libero G, and Mori L. Recognition of lipid antigens by T cells. Nat Rev Immunol 5: 485-496, 2005. de Wolf-Peeters C, Pittaluga S, Dierlamm J, Wlodarska I, and Van Den Berghe H. Marginal zone B-cell lymphomas including mucosa-associated lymphoid tissue type lymphoma (MALT), monocytoid B-cell lymphoma and splenic marginal zone cell lymphoma and their relation to the reactive marginal zone. Leuk Lymphoma 26: 467-478, 1997. Dorn CR, Taylor DO, Schneider R, Hibbard HH, and Klauber MR. Survey of animal neoplasms in Alameda and Contra Costa Counties, California. II. Cancer morbidity in dogs and cats from Alameda County. J Natl Cancer Inst 40: 307-318, 1968. Doster AR, Tomlinson MJ, Mahaffey EA, and Jordan CW. Canine liposarcoma. Vet Pathol 23: 84-87, 1986. Eberle N, von Babo V, Nolte I, Baumgärtner W, and Betz D. Splenic masses in dogs. Part 1: Epidemiologic, clinical characteristics as well as histopathologic diagnosis in 249 cases (2000-2011). Tierarztl Prax Ausg K Kleintiere Heimtiere 40: 250-260, 2012. Eichner ER. Splenic function: Normal, too much and too little. Am J Med 66: 311-320, 1979. Ellenberger C, Bartmann CP, Hoppen HO, Kratzsch J, Aupperle H, Klug E, Schoon D, and Schoon HA. Histomorphological and immunohistochemical characterization of equine granulosa cell tumours. J Comp Pathol 136: 167-176, 2007. Falk S, Krishnan J, and Meis JM. Primary angiosarcoma of the spleen. A clinicopathologic study of 40 cases. Am J Surg Pathol 17: 959-970, 1993. Feeney DA, Johnston GR, and Hardy RM. Two-dimensional, gray-scale ultrasonography for assessment of hepatic and splenic neoplasia in the dog and cat. J Am Vet Med Assoc 184: 68-81, 1984. Fife WD, Samii VF, Drost WT, Mattoon JS, and Hoshaw-Woodard S. Comparison Between Malignant and Nonmalignant Splenic Masses in Dogs using Contrast-Enhanced Computed Tomography. Vet Radiol Ultrasound 45: 289-297, 2004. Fredrickson TN, Lennert K, Chattopadhyay SK, Morse Iii HC, and Hartley JW. Splenic Marginal Zone Lymphomas of Mice. Am J Pathol 154: 805-812, 1999. Gamlem H, and Nordstoga K. Canine vascular neoplasia--histologic classification and inmunohistochemical analysis of 221 tumours and tumour-like lesions. APMIS Suppl 19-40, 2008. Göritz M, Müller K, Krastel D, Staudacher G, Schmidt P, Kühn M, Nickel R, and Schoon HA. Canine Splenic Haemangiosarcoma: Influence of Metastases, Chemotherapy and Growth Pattern on Post-splenectomy Survival and Expression of Angiogenic Factors. J Comp Pathol 149: 30-39, 2013. Gourley IM, Popp JA, and Park RD. Myelolipomas of the liver in a domestic cat. J Am Vet Med Assoc 158: 2053-2057, 1971. Hackstein H, and Thomson AW. Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. Nat Rev Immunol 4: 24-34, 2004. Hahn KA, Richardson RC, Hahn EA, and Chrisman CL. Diagnostic and prognostic importance of chromosomal aberrations identified in 61 dogs with lymphosarcoma. Vet Pathol 31: 528-540, 1994. Hammond TN, and Pesillo-Crosby SA. Prevalence of hemangiosarcoma in anemic dogs with a splenic mass and hemoperitoneum requiring a transfusion: 71 cases (2003–2005). J Am Vet Med Assoc 232: 553-558, 2008. Hanson JA, and Penninck DG. Ultrasonographic evaluation of traumatic splenic hematoma and literature review. Vet Radiol Ultrasound 35: 463-468, 1994. Hoffmann MV, Ludwig DC, Lempp C, Haist V, and Stein VM. Epidural myelolipoma in a Husky-cross: a case report. Acta Vet Scand 55: 28, 2013. Hosgood G, Bone DL, Iii WDV, and Reed WM. Splenectomy in the Dog by Ligation of the Splenic and Short Gastric Arteries. Vet Surg 18: 110-113, 1989. Hosgood G. Splenectomy in the dog: a retrospective study of 31 cases. J Am Anim Hosp Assoc 23: 1987. Ikede BO, and Downey RS. Case report. Multiple hepatic myelolipomas in a cat. Can Vet J 13: 160-163, 1972. Ivančić M, Long F, and Seiler GS. Contrast harmonic ultrasonography of splenic masses and associated liver nodules in dogs. J Am Vet Med Assoc 234: 88-94, 2009. Johnson KA, Powers BE, Withrow SJ, Sheetz MJ, Curtis CR, and Wrigley RH. Splenomegaly in dogs. Predictors of neoplasia and survival after splenectomy. J Vet Intern Med 3: 160-166, 1989. Johnson PJ, Wilson DA, Turk JR, Pace LW, Campbell-Beggs C, and Johnson GC. Disseminated peritoneal leiomyomatosis in a horse. J Am Vet Med Assoc 205: 725-728, 1994. Kadota K, and Nakajima H. Histological progression of follicular centre cell lymphomas to immunoglobulin-producing tumours in two pigs. J Comp Pathol 99: 145-158, 1988. Kaltreider HB, Barth E, and Pellegrini C. The effect of splenectomy on the appearance of specific antibody-forming cells in lungs of dogs after intravenous immunization with sheep erythrocytes. Exp Lung Res 2: 231-238, 1981. Kapatkin AS, Mullen HS, Matthiesen DT, and Patnaik AK. Leiomyosarcoma in dogs: 44 cases (1983-1988). J Am Vet Med Assoc 201: 1077-1079, 1992. King H, and Shumacker HB, Jr. Splenic studies. I. Susceptibility to infection after splenectomy performed in infancy. Ann Surg 136: 239-242, 1952. Knapp D, Aronsohn M, and Harpster N. Cardiac arrhythmias associated with mass lesions of the canine spleen. J Am Anim Hosp Assoc 29: 1993. Kojima D, Hatai H, Oyamada T, and Park CH. Extraskeletal myxoid chondrosarcoma with systemic metastasis in a five-month-old Irish setter dog. J Vet Med Sci 74: 1045-1049, 2012. Kuntz CA, Dernell WS, Powers BE, and Withrow S. Extraskeletal osteosarcomas in dogs: 14 cases. J Am Anim Hosp Assoc 34: 26-30, 1998. Langenbach A, Anderson MA, Dambach DM, Sorenmo KU, and Shofer FD. Extraskeletal osteosarcomas in dogs: a retrospective study of 169 cases (1986-1996). J Am Anim Hosp Assoc 34: 113-120, 1998. Liu DL, Xia S, Tang J, Qin X, and Liu H. Allotransplantation of whole spleen in patients with hepatic malignant tumors or hemophilia A. Operative technique and preliminary results. Arch Surg 130: 33-39, 1995. Locke JE, and Barber LG. Comparative Aspects and Clinical Outcomes of Canine Renal Hemangiosarcoma. J Vet Intern Med 20: 962-967, 2006. Lombard LS, Fortna HM, Garner FM, and Brynjolfsson G. Myelolipomas of the liver in captive wild Felidae. Pathol Vet 5: 127-134, 1968. Machida N, Arimura T, Otagiri Y, Kiryu K, and Oka T. Epithelioid haemangioendothelioma of the lung in a dog. J Comp Pathol 119: 317-322, 1998. Marino DJ, Matthiesen DT, Fox PR, Lesser MB, and Stamoulis ME. Ventricular arrhythmias in dogs undergoing splenectomy: a prospective study. Vet Surg 23: 101-106, 1994. Matsuno K, Ezaki T, and Kotani M. Splenic outer periarterial lymphoid sheath (PALS): an immunoproliferative microenvironment constituted by antigen-laden marginal metallophils and ED2-positive macrophages in the rat. Cell Tissue Res 257: 459-470, 1989. Mebius RE, and Kraal G. Structure and function of the spleen. Nat Rev Immunol 5: 606-616, 2005. Messick JB, and Radin MJ. Cytologic, histologic, and ultrastructural characteristics of a canine myxoid liposarcoma. Vet Pathol 26: 520-522, 1989. Meunier L, Gonzalez-Ramos A, and Cooper KD. Heterogeneous populations of class II MHC+ cells in human dermal cell suspensions. Identification of a small subset responsible for potent dermal antigen-presenting cell activity with features analogous to Langerhans cells. J Immunol 151: 4067-4080, 1993. Meunier L, Bata-Csorgo Z, and Cooper KD. In human dermis, ultraviolet radiation induces expansion of a CD36+ CD11b+ CD1- macrophage subset by infiltration and proliferation; CD1+ Langerhans-like dendritic antigen-presenting cells are concomitantly depleted. J Invest Dermatol 105: 782-788, 1995. Miller JM, Walshaw R, and Bourque AC. Primary splenic mesenchymal chondrosarcoma in a dog. Can Vet J 46: 163-165, 2005. Moe L, Gamlem H, Dahl K, and Glattre E. Canine neoplasia--population-based incidence of vascular tumours. APMIS Suppl 63-68, 2008. Mongil CM, Drobatz KJ, and Hendricks JC. Traumatic hemoperitoneum in 28 cases: a retrospective review. J Am Anim Hosp Assoc 31: 217-222, 1995. Moore AS, Leveille CR, Reimann KA, Shu H, and Arias IM. The expression of P-glycoprotein in canine lymphoma and its association with multidrug resistance. Cancer Invest 13: 475-479, 1995. Moore AS, Frimberger AE, Sullivan N, and Moore PF. Histologic and immunohistochemical review of splenic fibrohistiocytic nodules in dogs. J Vet Intern Med 26: 1164-1168, 2012. Moore PF, Affolter VK, and Vernau W. Canine hemophagocytic histiocytic sarcoma: a proliferative disorder of CD11d+ macrophages. Vet Pathol 43: 632-645, 2006. Moore PF. A review of histiocytic diseases of dogs and cats. Vet Pathol 51: 167-184, 2014. Morandi F, Mays JL, Newman SJ, and Adams WH. Imaging diagnosis--bilateral adrenal adenomas and myelolipomas in a dog. Vet Radiol Ultrasound 48: 246-249, 2007. Morrison WB, and DeNicola DB. Advantages and disadvantages of cytology and histopathology for the diagnosis of cancer. Semin Vet Med Surg (Small Anim) 8: 222-227, 1993. Munday JS, and Prahl A. Retroperitoneal extraskeletal mesenchymal chondrosarcoma in a dog. J Vet Diagn Invest 14: 498-500, 2002. Naka N, Ohsawa M, Tomita Y, Kanno H, Uchida A, Myoui A, and Aozasa K. Prognostic factors in angiosarcoma: a multivariate analysis of 55 cases. J Surg Oncol 61: 170-176, 1996. Nakashima Y, Unni KK, Shives TC, Swee RG, and Dahlin DC. Mesenchymal chondrosarcoma of bone and soft tissue. A review of 111 cases. Cancer 57: 2444-2453, 1986. Nolte MA, Hamann A, Kraal G, and Mebius RE. The strict regulation of lymphocyte migration to splenic white pulp does not involve common homing receptors. Immunology 106: 299-307, 2002. Oakes DD. Splenic trauma. Curr Probl Surg 18: 341-401, 1981. Ogilvie GK, Powers BE, Mallinckrodt CH, and Withrow SJ. Surgery and doxorubicin in dogs with hemangiosarcoma. J Vet Intern Med 10: 379-384, 1996. Oksanen A. Haemangiosarcoma in dogs. J Comp Pathol 88: 585-595, 1978. Paik HH, and Komorowski R. Hemangiosarcoma of the abdominal wall following irradiation therapy of endometrial carcinoma. Am J Clin Pathol 66: 810-814, 1976. Pardo AD, Adams WH, McCracken MD, and Legendre AM. Primary jejunal osteosarcoma associated with a surgical sponge in a dog. J Am Vet Med Assoc 196: 935-938, 1990. Patnaik AK. Canine extraskeletal osteosarcoma and chondrosarcoma: a clinicopathologic study of 14 cases. Vet Pathol 27: 46-55, 1990. Pintar J, Breitschwerdt EB, Hardie EM, and Spaulding KA. Acute nontraumatic hemoabdomen in the dog: a retrospective analysis of 39 cases (1987-2001). J Am Anim Hosp Assoc 39: 518-522, 2003. Pires MA, Seixas F, Palmeira C, and Payan-Carreira R. Histopathologic and immunohistochemical exam in one case of canine endometrial adenocarcinoma. Reprod Domest Anim 45: 545-549, 2010. Ponce F, Magnol JP, Marchal T, Chabanne L, Ledieu D, Bonnefont C, Felman P, and Fournel-Fleury C. High-grade canine T-cell lymphoma/leukemia with plasmacytoid morphology: a clinical pathological study of nine cases. J Vet Diagn Invest 15: 330-337, 2003. Prymak C, McKee LJ, Goldschmidt MH, and Glickman LT. Epidemiologic, clinical, pathologic, and prognostic characteristics of splenic hemangiosarcoma and splenic hematoma in dogs: 217 cases (1985). J Am Vet Med Assoc 193: 706-712, 1988. Ramos-Vara JA, Webster JD, Dusold D, and Miller MA. Immunohistochemical Evaluation of the Effects of Paraffin Section Storage on Biomarker Stability. Vet Pathol 2013. Rao P, Kenney PJ, Wagner BJ, and Davidson AJ. Imaging and pathologic features of myelolipoma. Radiographics 17: 1373-1385, 1997. Rassnick KM, Mauldin GE, Al-Sarraf R, Mauldin GN, Moore AS, and Mooney SC. MOPP chemotherapy for treatment of resistant lymphoma in dogs: a retrospective study of 117 cases (1989-2000). J Vet Intern Med 16: 576-580, 2002. Restucci B, Borzacchiello G, Maiolino P, Martano M, Paciello O, and Papparella S. Expression of Vascular Endothelial Growth Factor Receptor Flk-1 in Canine Mammary Tumours. J Comp Pathol 130: 99-104, 2004. Rhind SM, and Welsh E. Mesenchymal chondrosarcoma in a young German shepherd dog. J Small Anim Pract 40: 443-445, 1999. Rosenberg MP, Matus RE, and Patnaik AK. Prognostic factors in dogs with lymphoma and associated hypercalcemia. J Vet Intern Med 5: 268-271, 1991. Rudiger T, Ichinohasama R, Ott MM, Muller-Deubert S, Miura I, Ott G, and Muller-Hermelink HK. Peripheral T-cell lymphoma with distinct perifollicular growth pattern: a distinct subtype of T-cell lymphoma? Am J Surg Pathol 24: 117-122, 2000. Saito H, Yokoi Y, Watanabe S, Tajima J, Kuroda H, and Namihisa T. Reticular meshwork of the spleen in rats studied by electron microscopy. Am J Anat 181: 235-252, 1988. Sander CH, and Langham RF. Myelolipoma of the spleen in a cat. J Am Vet Med Assoc 160: 1101-1103, 1972. Satodate R, Tanaka H, Sasou S, Sakuma T, and Kaizuka H. Scanning electron microscopical studies of the arterial terminals in the red pulp of the rat spleen. Anat Rec 215: 214-216, 1986. Schena CJ, Stickle RL, Dunstan RW, Trapp AL, Reimann KA, White JV, Killingsworth CR, and Hauptman JG. Extraskeletal osteosarcoma in two dogs. J Am Vet Med Assoc 194: 1452-1456, 1989. Schultheiss PC. A retrospective study of visceral and nonvisceral hemangiosarcoma and hemangiomas in domestic animals. J Vet Diagn Invest 16: 522-526, 2004. Schwarz LA, Penninck DG, and Gliatto J. Ultrasound corner canine splenic myelolipomas. Vet Radiol Ultrasound 42: 347-348, 2001. Sherman R. Perspectives in management of trauma to the spleen: 1979 presidential address, American Association for the Surgery of Trauma. J Trauma 20: 1-13, 1980. Shortman K, and Caux C. Dendritic cell development: multiple pathways to nature's adjuvants. Stem Cells 15: 409-419, 1997. Shortman K, and Liu YJ. Mouse and human dendritic cell subtypes. Nat Rev Immunol 2: 151-161, 2002. Sorenmo KU, Baez JL, Clifford CA, Mauldin E, Overley B, Skorupski K, Bachman R, Samluk M, and Shofer F. Efficacy and toxicity of a dose-intensified doxorubicin protocol in canine hemangiosarcoma. J Vet Intern Med 18: 209-213, 2004. Spangler WL, and Kass PH. Pathologic and prognostic characteristics of splenomegaly in dogs due to fibrohistiocytic nodules: 98 cases. Vet Pathol 35: 488-498, 1998. Spangler WL, and Kass PH. Pathologic Factors Affecting Postsplenectomy Survival in Dogs. J Vet Intern Med 11: 166-171, 1997. Spangler WL, and Culbertson MR. Prevalence and type of splenic diseases in cats: 455 cases (1985-1991). J Am Vet Med Assoc 201: 773-776, 1992. Spangler WL, and Culbertson MR. Prevalence, type, and importance of splenic diseases in dogs: 1,480 cases (1985-1989). J Am Vet Med Assoc 200: 829-834, 1992. Spangler WL, and Culbertson MR. Prevalence, type, and importance of splenic diseases in dogs: 1,480 cases (1985-1989). J Am Vet Med Assoc 200: 829-834, 1992. Spangler WL, Culbertson MR, and Kass PH. Primary Mesenchymal (Nonangiomatous/Nonlymphomatous) Neoplasms Occurring in the Canine Spleen: Anatomic Classification, Immunohistochemistry, and Mitotic Activity Correlated with Patient Survival. Vet Pathol 31: 37-47, 1994. Srebernik N, and Appleby EC. Breed prevalence and sites of haemangioma and haemangiosarcoma in dogs. Vet Rec 129: 408-409, 1991. Stark DD, Wittenberg J, Butch RJ, and Ferrucci JT. Hepatic metastases: randomized, controlled comparison of detection with MR imaging and CT. Radiology 165: 399-406, 1987. Storms G, and Janssens G. Intraocular myelolipoma in a dog. Vet Ophthalmol 16 Suppl 1: 183-187, 2013. Teske E. Canine malignant lymphoma: a review and comparison with human non-Hodgkin's lymphoma. Vet Q 16: 209-219, 1994. Vail DM, and MacEwen EG. Spontaneously occurring tumors of companion animals as models for human cancer. Cancer Invest 18: 781-792, 2000. Valli VE, Vernau W, de Lorimier LP, Graham PS, and Moore PF. Canine indolent nodular lymphoma. Vet Pathol 43: 241-256, 2006. Valli VE, San Myint M, Barthel A, Bienzle D, Caswell J, Colbatzky F, Durham A, Ehrhart EJ, Johnson Y, Jones C, Kiupel M, Labelle P, Lester S, Miller M, Moore P, Moroff S, Roccabianca P, Ramos-Vara J, Ross A, Scase T, Tvedten H, and Vernau W. Classification of canine malignant lymphomas according to the World Health Organization criteria. Vet Pathol 48: 198-211, 2011. Vinayak A, and Krahwinkel D. Managing blunt trauma-induced hemoperitoneum in dogs and cats. Compend Contin Educ Pract Vet 26: 276-291, 2004. von Beust BR, Suter MM, and Summers BA. Factor VIII-related antigen in canine endothelial neoplasms: an immunohistochemical study. Vet Pathol 25: 251-255, 1988. Wang FI, Liang SL, Eng HL, Jeng CR, and Pang VF. Disseminated liposarcoma in a dog. J Vet Diagn Invest 17: 291-294, 2005. Ward H, Fox LE, Calderwood-Mays MB, Hammer AS, and Couto CG. Cutaneous hemangiosarcoma in 25 dogs: a retrospective study. J Vet Intern Med 8: 345-348, 1994. Weinstein MJ, Carpenter JL, and Schunk CJ. Nonangiogenic and nonlymphomatous sarcomas of the canine spleen: 57 cases (1975-1987). J Am Vet Med Assoc 195: 784-788, 1989. Whittemore JC, Preston CA, Kyles AE, Hardie EM, and Feldman EC. Nontraumatic rupture of an adrenal gland tumor causing intra-abdominal or retroperitoneal hemorrhage in four dogs. J Am Vet Med Assoc 219: 329-333, 324, 2001. Wood C, Moore A, Gliatto J, Ablin L, Berg R, and Rand W. Prognosis for dogs with stage I or II splenic hemangiosarcoma treated by splenectomy alone: 32 cases (1991-1993). J Am Anim Hosp Assoc 34: 417-421, 1998. Wrigley RH, Konde L, Park R, and Lebel J. Clinical features and diagnosis of splenic hematomas in dogs: 10 cases (1980 to 1987). J Am Anim Hosp Assoc 25: 1989. Wrigley RH, Park RD, Konde LJ, and Lebel JL. Ultrasonographic features of splenic hemangiosarcoma in dogs: 18 cases (1980-1986). J Am Vet Med Assoc 192: 1113-1117, 1988. Yonemaru K, Sakai H, Murakami M, Yanai T, and Masegi T. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and their receptors (flt-1, flk-1, and flg-1) in canine vascular tumors. Vet Pathol 43: 971-980, 2006. Zimmer MA, and Stair EL. Splenic myelolipomas in two dogs. Vet Pathol 20: 637-638, 1983. Zwicker GM. Liposarcoma in a dog. Pathol Vet 7: 145-147, 1970. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/16884 | - |
dc.description.abstract | 脾臟是犬體內最大的次級淋巴器官,約含有體內四分之一的淋巴細胞。脾臟腫大(Splenomegaly)在犬有較高發生率。傳統的外科手術認知認為脾臟血管肉瘤是最常見的犬脾臟腫大形式。但近期的文獻提出反對的證據,根據這些研究,在犬脾臟腫大中的惡性腫瘤的病例與非惡性病變的病例皆約佔一半。而犬脾臟本身包含相當多樣複雜的組織:淋巴、血管組織和其它各式各樣不同的組織所構成,因此所以相當多種類腫瘤都曾在犬脾臟都被報告過。而臺灣仍未報告過犬脾臟疾病的回溯性研究,因此我們希望了解臺灣的脾臟疾病是否會有地區性的差別。某些脾臟疾病會因為併發病變而造成區別診斷上的困難,在過去的文獻曾報告特定的關聯性病變能輔助脾臟疾病診斷。
本研究為探討臺灣犬脾臟近五年外科檢體病理診斷的概況;並選定三種脾臟疾病常見之關聯性病變:壞死(Necrosis)、淋巴樣增生(Lymphoid hyperplasia)、含鐵小結(Siderotic nodule)評估在診斷中出現的情況。所收集之165例病例診斷,惡性腫瘤診斷有61例;非惡性病變診斷有104例。惡性腫瘤中以血管肉瘤(Hemangiosarcoma)占最多數有23例。淋巴瘤(Lymphoma)為第二常見之診斷有11例。而本研究中血管肉瘤的比例要比過往的外國研究來的低。非惡性病變病例中占最多數為血腫(Hematoma)有27例,與結節性增生(Nodular hyperplasia)併發血腫有15例。結節性增生和血腫同樣於非惡性疾病中的比例也和以往的研究有所不同。有二項關聯性病變與診斷分類之間出現顯著相關:可見壞死在肉瘤類別較常見;血腫在良性病變與肉瘤較常見;淋巴樣增生在良性病變較常見。總結本研究中的發現,在本次研究中有數種脾臟腫瘤與良性病變呈現出與以往研究不同比例。推測造成的原因是臺灣較多飼養小型犬品種。 | zh_TW |
dc.description.abstract | Spleen is the largest secondary lymphoid organ containing about one-fourth of the body’s lymphocytes in dog. Conventional surgical wisdom implies that splenic hemangiosarcoma is the most prevalent of dog splenomegaly. However, recent studies provide evidence against this. According to these studies, malignant tumor and non-malignant lesion are population of about half in dog splenomegaly. The dog spleen is composed of complex tissues: lymphoid, vascular, and other compartment, so variable tumors had be reported in dog. The retrospective study for canine splenic diseases had been not reported in Taiwan, so we want to know classification of splenic disease which have or not regional difference. Some splenic diseases present complicated lesion because spleen is the organ with complex tissue, it causes difficult to differentiate from variable spleen disease. In previous studies, some associated lesions can help pathological diagnosis.
The present study is to investigate histopathological distribution of canine spleen disease from surgical specimen in recent five years in Taiwan; and selected three common associated lesions in splenic disease: necrosis, lymphoid hyperplasia, and siderotic nodule to study correlation between the associated lesions and histopathological diagnostic type. A total of 165 cases enrolled in this studies, they were diagnosed histologically as 104 of non-malignant disease and 61 of malignant splenic tumor. Hemangiosarcoma was the most common malignant histological diagnosis (n=23). The second common was lymphoma (n=11). The percentage of hemangiosarcoma in malignant tumor are lower than previous foreign studies. The most common of non-malignant disease were splenic hematoma (n =27), and nodular hyperplasia with hematoma (n =15). The percentage of nodular hyperplasia and hematoma in non-malignant disease were also different than previous studies. Two correlation between the histopathological diagnostic type and associated lesions were significant: necrosis is more common in sarcoma type; lymphoid hyperplasia are more common in benign lesions type. In conclusion, several splenic malignant tumors and non-malignant diseases present the different population compare previous studies. It’s considered by more population small breeds in Taiwan. | en |
dc.description.provenance | Made available in DSpace on 2021-06-07T23:48:51Z (GMT). No. of bitstreams: 1 ntu-103-R99629014-1.pdf: 3606423 bytes, checksum: 71ba41c4cd13438b9b252fea2e9da871 (MD5) Previous issue date: 2014 | en |
dc.description.tableofcontents | 中文摘要 I
Abstract II 第一章 前言 1 第二章 文獻探討 3 2.1犬脾臟生理結構 3 2.2犬脾臟臨床檢查與治療 5 2.3犬脾臟非腫瘤性病理變化之研究 5 2.3.1結節樣增生與血腫 6 2.4犬脾臟腫瘤研究 7 2.4.1良性腫瘤 7 2.4.2血管肉瘤 8 2.4.3 淋巴瘤 9 2.4.4 其它肉瘤 10 第三章 材料與方法 14 3.1實驗設計與流程 14 3.2 材料來源 14 3.2.1 基本資料與病史 14 3.3 型態病理學檢查 15 3.3.1 常規組織病理切片製作之藥品、試劑與儀器 15 3.3.2 實驗方法 16 3.4 免疫組織化學染色 17 3.4.1免疫組織化學染色藥品試劑與材料 17 3.4.2免疫組織化學染色方法 18 3.5 評估免疫組織化學染色 20 3.6 病理變化統計 20 3.7 統計分析 20 第四章 結果 22 4.1 病例基本資料 22 4.2 病例臨床數據 24 4.3 病理組織學分類 26 4.4 病變與診斷之相關性 29 第五章 討論 31 5.1病例基本資料分析 31 5.2病例臨床數據分析 33 5.3病例組織學型態分析 34 5.4關聯性病變因子與診斷分析 37 5.5結論 38 第六章 圖次與表次 40 6.1表次 40 Table 1. Histological Classification of Hematopoietic Tumors of Domestic Animals. 40 Table 2. Source and dilutions of the antibodies used in this study. 43 Table 3. Signalments of the 165 dogs in this study. 44 Table 4. Patient genders of malignant tumor (MT) versus non-malignant lesion (NML) in 165 dogs of this study. 45 Table 5. Presenting Clinical signs of malignant tumor (MT) versus non-malignant lesion (NML) in 63 dogs with a complete medical record. 46 Table 6. Marks expression of canine tumors in immunochemistry. 47 Table 7. Histopathological distribution of splenic specimens in 165 dogs of this study. 49 Table 8. Histopathological distribution of splenic specimens in 36 dogs of large breeds. 50 Table 10. Histopathological distribution of splenic specimens in 71 dogs of small breeds. 52 Table 11. Histopathological distribution of splenic specimens in 49 dogs of mogerl. 53 Table 12. Histopathological distribution of splenic specimens in 114 dogs with nodular splenomegaly. 54 Table 13. Histopathological distribution of splenic specimens in 21 dogs with diffuse splenomegaly. 55 Table 14. Correlation between the associated lesions in 165 dogs of this study. 56 Table 15. Correlation between the associated lesions and diagnosis in 165 dogs of this study. 57 6.2圖次 58 Figure 1. Immunochemistry stain of Cytokertain, Vimentin, CD31, Desmin, α-smooth muscle in this study. 58 Figure 2. Immunochemistry stain of hematolymphoid marks in canine spleen. 60 Figure 3. H&E and immunochemistry stain of hemangiosarcoma in canine spleen. 61 Figure 4. H&E and immunochemistry stain of lymphoma in canine spleen. 62 Figure 5. H&E stain of extraskeletal osteosarcoma and chondrosarcoma in canine spleen. 63 Figure 6. Benign tumors and non-neoplastic lesions in canine spleen. 64 Figure 7. Three associated lesions were statistics in this study. 65 Figure 8. Complete blood count (CBC) in 63 dogs with a complete medical record. 66 第七章 參考文獻 67 | |
dc.language.iso | zh-TW | |
dc.title | 犬脾臟病理變化之回溯性研究 | zh_TW |
dc.title | The Retrospective Studies on Pathological Lesions of Canine Spleen | en |
dc.type | Thesis | |
dc.date.schoolyear | 102-1 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 廖泰慶,林正忠,朱旆億 | |
dc.subject.keyword | 犬脾臟,腫瘤,免疫化學染色,血管肉瘤,淋巴瘤, | zh_TW |
dc.subject.keyword | Canine spleen,tumor,immunohistochemistry,hemangiosarcoma,lymphoma, | en |
dc.relation.page | 76 | |
dc.rights.note | 未授權 | |
dc.date.accepted | 2014-02-14 | |
dc.contributor.author-college | 獸醫專業學院 | zh_TW |
dc.contributor.author-dept | 獸醫學研究所 | zh_TW |
顯示於系所單位: | 獸醫學系 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-103-1.pdf 目前未授權公開取用 | 3.52 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。